
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2025 Earnings Call Transcript May 7, 2025 ACADIA Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.11, expectations were $0.1. Al Kildani – SVP of IR & Corporate Communications: Catherine …